-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Agile Therapeutics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
- Agile Therapeutics Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$9.13M, a 793% decline year-over-year.
- Agile Therapeutics Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$2.3M, a 113% decline year-over-year.
- Agile Therapeutics Inc annual Nonoperating Income (Expense) for 2023 was $5.42M, a 75.9% decline from 2022.
- Agile Therapeutics Inc annual Nonoperating Income (Expense) for 2022 was $22.5M.
- Agile Therapeutics Inc annual Nonoperating Income (Expense) for 2021 was -$62K, a 97.8% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)